- Treatment of thyroid cancer - a serious approach
- Therapies
- Preparations
Therapies
External radiotherapy
Externalities or external radiation therapy - a treatment using radiation, directed externally to the affected areas of the body. Usually it is used to treat thyroid cancer in the late stages, or anaplastic carcinoma.
The duration of treatment will depend on the type of cancer and its rate of growth. Side effects of radiotherapy:
- Nausea;
- Vomiting;
- Fatigue;
- Pain when swallowing;
- Dry mouth.
These side effects are usually tested after 2-3 weeks after radiotherapy.
Chemotherapy
Usually, chemotherapy is used only to treat anaplastic thyroid cancer, gave metastasized to other areas of the body.
Chemotherapy - a treatment with powerful drugs to kill cancer cells. She rarely successful cures anaplastic cancer, but can slow its development and alleviate symptoms.
Possible side effects of chemotherapy:
- Nausea;
- Vomiting;
- Fatigue;
- Lack of appetite;
- Hair loss;
- The formation of ulcers in the mouth.
In addition, people who are undergoing chemotherapy, are more prone to various infections.
Targeted therapy
Currently, clinical trials are several types of targeted therapies for cancer treatment of medullary thyroid cancer
Medullary thyroid cancer: identification of disease
in the later stages, differentiated thyroid cancer is not treatable with radioactive iodine, and anaplastic cancer.
Targentnaya or targeted therapy involves the use of medications that target biological functions required for cancer growth and spread. For example, there is an enzyme that promotes the growth of cancer cells. Preparation for targeted therapy, known as a tyrosine kinase inhibitor, specifically designed to block the action of this enzyme. Tyrosine kinase inhibitors are, for example, sunitinib and sorafenib.
None of the currently available tyrosine kinase inhibitors has not been approved as a drug for treatment of thyroid cancer
Thyroid cancer: it is curable
As to ensure their efficacy and safety is not enough data.
A specialist may recommend taking drugs of this type, if:
- In his opinion, the likelihood that the drug will be effective, is very high;
- The best alternatives for treatment available;
- The possible benefits of treatment are larger than the associated risks.
If the doctor decides to appoint a patient receiving tyrosine kinase inhibitors, it should inform him about all the possible benefits and risks, as well as the fact that the drug is not officially approved for the treatment of thyroid cancer.
Tyrosine kinase inhibitors - are very powerful drugs that can cause many side effects, including:
- Burning and soreness in the language;
- Stomach upset;
- Nausea;
- Vomiting;
- Diarrhea;
- Symptoms are similar to flu symptoms, such as fever and muscle pain;
- Loss of appetite.
As a rule, patients rarely has the opportunity to assign patients to these drugs. Another possibility is to take them - participation in clinical trials. However, it should be borne in mind that there is no guarantee that the experimental therapy would be more effective than available in conventional hospitals traditional therapies.
New therapy for thyroid cancer: a long life
Scientists have discovered a new, aggressive treatment for anaplastic thyroid cancer, which can dramatically increase the survival of patients with this disease.
The new approach is based on the need to aggressively treat metastasized, even if the cancer probably is growing only within the neck.
Traditionally, anaplastic thyroid cancer
Thyroid cancer: it is curable
treated by surgery and radiotherapy, but because of its rapid spread annual survival was only 20%. Since the prognosis for patients with this diagnosis unfavorable, the scientists decided that a more aggressive approach to treatment.
Of the 24 patients who participated in the study, 10 underwent a new type of therapy for anaplastic thyroid cancer. After the surgery he was appointed intensive modulated radiotherapy and aggressive chemotherapy - these two methods were to simultaneously monitor the development of tumors in the thyroid gland
The thyroid gland - is responsible for your hormones
and to prevent the appearance of distant metastases.
One-year survival in these patients was 70%, six out of ten subjects stayed for at least two years after the cessation of therapy, while five of these symptoms were absent. Two patients in the test group were aggressive treatment of more than three years ago and they are still saved in remission.